DigitalCFO Newsroom | 20 April 2022
Esker, today announced that Juniper Biologics has selected them to automate its accounts payable (AP) processes.
Esker, a global cloud platform and leader in AI-driven process automation solutions for finance and customer service functions, today announced that Juniper Biologics,a science-led healthcare company focused on Researching, Developing and Commercialising novel therapies, has selected Esker to automate its accounts payable (AP) processes.
With Esker, Juniper Biologics intends to digitally transform its AP operations into a highly collaborative, efficient and visible process. Eliminating manual tasks and processing invoices on a single platform, Esker’s Accounts Payable solution will support Juniper Biologics in improving operational efficiency by giving employees and suppliers the visibility and information they need to speed up the AP process.
Learn more: https://www.esker.com.sg/company/press-releases/esker-automate-juniper-biologics-accounts-payable-processes/
